Global Medical Cyclotrons Market By Product Type (Cyclotron 10-12 MeV, Cyclotron 16-18 MeV, Cyclotron 19-24 MeV, and Cyclotron 24 MeV & above), By Application (Hospitals, and Institutes), By Region and Companies - Industry Segment Outlook, Market Assessment, Competition Scenario, Trends and Forecast 2022-2032

Medical Cyclotron Market Overview:

In 2021, the global market for medical cyclotrons was worth USD 180.6 million. The market is expected to grow at a CAGR in excess of 10.7% over the forecast period.

Market growth is driven by the rising incidence of cancer and a growing preference for nuclear scans to provide an accurate diagnosis. There are also cost advantages over outsourced radioactive tracer tracers.

Global Medical Cyclotrons Market Scope:

Product Type Analysis

The market can be divided into four segments based on product: 10-12 MeV to 16-18 MeV, 19-24 MeV, 24 MeV, and higher. The market was dominated by cyclotrons between 16 and 18 MeV, which accounted for over 53.4% of total market revenue in 2021. This segment’s growth can be attributed to the rising demand for nuclear scans and the growing prevalence of cancer. A significant share of the market is also held by cyclotrons with a range between 10-12 MeV. They are used in hospitals and diagnostic centers that perform nuclear scans.

The cyclotrons that are in the 10-12 MeV range are smaller than other particle accelerators. There are two options available for healthcare professionals: shielded and unshielded. Dual-particle capability is provided by these devices, which are capable of absorbing dual-target radiations such as a proton beam current between 60 mA and 130 mA or a deuteron beam current between 60 mA and 60 mA. The Asia Pacific is home to the most cyclotrons within the 16-18 MeV range, due to the higher demand for nuclear scans at hospitals and diagnostic centers.

The demand for medical cyclotrons will rise due to the increasing acceptance of PET-associated medical accelerators in the diagnosis and treatment of cancer. The demand for nuclear scans is increasing due to increased awareness of cancer. The global medical cyclotron market is expected to grow due to increased demand for nuclear scans, and an increase in awareness about cancer.

Кеу Маrkеt Ѕеgmеntѕ:

By Product Type

• Cyclotron 16-18 MeV
• Cyclotron 10-12 MeV
• Cyclotron 19-24 MeV
• Cyclotron 24 MeV & above

By Application

• Hospital
• Institute

Market Dynamics:

Global demand is driven by the increasing need for products with advantages like ease of installation, low maintenance costs, and flexibility in creating complex shapes. The changing needs of consumers are driving the demand for new products, such as concrete, steel, and polyvinyl chloride.

Markets are becoming more popular as viable alternatives to traditional ones due to longer-lasting durability, higher corrosion resistance, and easier handling due to the lower weight. As a result, the market is seeing a rise in acceptance of its use in various applications. Medical cyclotrons offer many advantages, including the ability to manufacture the product in various sizes and shapes to meet customer requirements in a wide range of applications. Because there is less friction between the product’s surfaces, excellent hydraulic features can be maintained.

Regional Analysis:

In 2021, the North American region accounted for 38.7% of the revenue share of the global market. Due to the increasing demand for nuclear scans, and the growing number of cancer patients, the region will continue to dominate the market throughout the forecast period. The region’s market is also growing due to increased investments in healthcare infrastructure, the shutting down of nuclear reactors, and the increasing demand for cost-effective solutions.

Over the forecast period, the European market will experience a CAGR in excess of 11.3%. Europe is expected to have the second-largest volume share during the forecast period. Due to high cancer prevalence, rising awareness about nuclear scans, and increasing awareness, the region will continue to be a major market player.

The International Atomic Energy Agency is an international regulatory body that allows the installation of particle accelerators. The IAEA has strict regulations that must be followed when installing these devices in any European nation. These clearly defined regulatory guidelines are important to ensure patient safety around radioactive devices.

Key Regions and Countries covered іn thе rероrt:

• North America
  • US
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Russia
  • Spain
  • Rest of Europe
• APAC
  • China
  • Japan
  • South Korea
  • India
  • Rest of Asia-Pacific
• South America
  • Brazil
  • Argentina
  • Rest of South America
• MEA
  • GCC
  • South Africa
  • Israel
  • Rest of MEA

Market Share & Key Players Analysis:

A few players dominate the market: IBA, GE Healthcare, Siemens Medical Solutions USA, Inc., Advanced Cyclotron Systems, Sumitomo Heavy Industries, Ltd., and TeamBest (Best Medical International, Inc.).
Due to the oligopoly of the market, there is intense competition among existing players. Manufacturers are faced with high market entry barriers, strict regulatory compliance, and higher manufacturing costs.

There are very few companies that have a greater market share than others. TeamBest, however, is developing a product that has a 400 MeV capacity for particle therapy with heavy Ions. This will allow for a better diagnosis and treatment of the disease.

Маrkеt Кеу Рlауеrѕ:

• IBA
• GE Healthcare
• Siemens Medical Solutions USA, Inc.
• Advanced Cyclotron Systems
• Sumitomo Heavy Industries
• TeamBest inc.
• ACSIand Best Medical
• Wild Irish Seaweeds
• Other Key Players

For the Medical Cyclotron Market research study, the following years have been considered to estimate the market size: